According to filings with the U.S. Securities and Exchange Commission, Paige.ai is raising $38,999,891.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Andy Moye played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Paige.ai
Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.

To learn more about Paige.ai, visit http://paige.ai/

Contact:
Andy Moye, Chief Executive Officer
347-972-2040
https://www.linkedin.com/in/andymoye/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.